Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fezolamine 是一种新型可口服的非三环类化合物,具有抗抑郁活性。它在体外阻断[3H]去甲肾上腺素的突触体摄取方面的选择性是摄取[4H]3-羟色胺或[3H]多巴胺的3至2倍。在使用单胺耗尽动物的经典行为测试中,它阻止了利血平和四苯的抑制作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 780 | 现货 | ||
5 mg | ¥ 1,850 | 现货 | ||
10 mg | ¥ 2,730 | 现货 | ||
25 mg | ¥ 4,570 | 现货 | ||
50 mg | ¥ 6,490 | 现货 | ||
100 mg | ¥ 8,890 | 现货 | ||
500 mg | ¥ 17,800 | 现货 |
产品描述 | Fezolamine is a novel orally available non-tricyclic compound with antidepressant activity. It is three to two times more selective in blocking synaptosomal uptake of [3H]norepinephrine than uptake of [4H]3-hydroxytryptamine or [3H]dopamine in vitro. It blocked the inhibitory effects of rifampicin and tetraphenyl in classical behavioral tests using monoamine-depleted animals. |
体内活性 | Fezolamine (100-450 mg/day; oral; 6 weeks; 42 patients) significant improvement relative to the patient's prestudy state was observed after 2 weeks in both patient and physician-rating scales. Fifty-five percent of patients improved their Hamilton Psychiatric Rating Scale for Depression (HAM-D) scores by more than 50%. The median dose associated with a clinically significant response was 245 mg/day. Five of the 6 patients who dropped out did so because of gastrointestinal adverse effects. The most common adverse effects were nausea (36%), headache (29%), constipation (26%), and dry mouth (24%).[1] |
分子量 | 305.42 |
分子式 | C20H23N3 |
CAS No. | 80410-36-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (180.08 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.2742 mL | 16.3709 mL | 32.7418 mL | 81.8545 mL |
5 mM | 0.6548 mL | 3.2742 mL | 6.5484 mL | 16.3709 mL | |
10 mM | 0.3274 mL | 1.6371 mL | 3.2742 mL | 8.1854 mL | |
20 mM | 0.1637 mL | 0.8185 mL | 1.6371 mL | 4.0927 mL | |
50 mM | 0.0655 mL | 0.3274 mL | 0.6548 mL | 1.6371 mL | |
100 mM | 0.0327 mL | 0.1637 mL | 0.3274 mL | 0.8185 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Fezolamine 80410-36-2 Neuroscience Norepinephrine Inhibitor inhibitor inhibit